Romain Villéger

Has grant

Maître de Conférences / Associate professor

University of Poitiers

France

Research Interests

Explore related searches

Professors in France Professors in Microbiology Microbiology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Romain Villéger is an Associate Professor at the University of Poitiers in France. His research primarily focuses on the interactions between the gut microbiota and cancer, investigating topics such as bacterial virulence, the role of colibactin in colorectal cancer, and the impact of endocrine disruptors on microbial behavior. Recent publications reflect his expertise in microbial pathogenesis and its implications for cancer therapy.

Recent Grants

Grant: Close

SoXIAL

Open Date: 2021-10-01

Close Date: 2024-09-01

Articles (11)

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Vincent Sol

FRANCE

View details

nathalie ROLHION

INSERM

FRANCE

View details

Frédéric A. Carvalho

Université Clermont Auvergne

FRANCE

View details

Tan-sothea OUK

Lecturer

Université de Limoges

FRANCE

View details

Nicolas Barnich

Université Clermont Auvergne

FRANCE

View details

Marvin Edeas

Professor (Visiting)

FRANCE

View details

Agata Mulak

Wroclaw Medical University

POLAND

View details

Mathilde Bonnet

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Romain Villéger

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

L-serine promotes pro-carcinogenic effects of colibactin-producing <i>E. coli</i>

Legionella pneumophila subverts the antioxidant defenses of its amoeba host Acanthamoeba castellanii

Effect of endocrine disruptors on bacterial virulence

Prebiotic Isomaltooligosaccharide Provides an Advantageous Fitness to the Probiotic Bacillus subtilis CU1

Microbiota medicine: towards clinical revolution

AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms.

Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer.

Deletion of cystathionine-γ-lyase in bone marrow-derived cells promotes colitis-associated carcinogenesis.

Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing <i>Escherichia coli</i> in Colorectal Cancer

Colibactin-positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer.

Matrix metalloproteinases cleave membrane-bound PD-L1 on CD90+ (myo-)fibroblasts in Crohn's disease and regulate Th1/Th17 cell responses

Collaborators (8)

Vincent Sol

nathalie ROLHION

Frédéric A. Carvalho

Tan-sothea OUK

Nicolas Barnich

Marvin Edeas

Agata Mulak

Mathilde Bonnet

Make your next move.